

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 6.28968941 |
| 2 | valine metabolic process (GO:0006573) | 5.91469951 |
| 3 | urate metabolic process (GO:0046415) | 5.59439123 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.50717556 |
| 5 | * regulation of vitamin D biosynthetic process (GO:0060556) | 5.33032859 |
| 6 | protein retention in ER lumen (GO:0006621) | 5.30553713 |
| 7 | drug transport (GO:0015893) | 5.22493356 |
| 8 | phosphate ion transport (GO:0006817) | 5.08069491 |
| 9 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.99134296 |
| 10 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.75982297 |
| 11 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 4.75139119 |
| 12 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.72574391 |
| 13 | regulation of chronic inflammatory response (GO:0002676) | 4.71845631 |
| 14 | organic cation transport (GO:0015695) | 4.69325765 |
| 15 | negative regulation of interleukin-12 production (GO:0032695) | 4.68081829 |
| 16 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 4.58662483 |
| 17 | response to peptidoglycan (GO:0032494) | 4.57686391 |
| 18 | relaxation of cardiac muscle (GO:0055119) | 4.44404765 |
| 19 | T-helper 1 type immune response (GO:0042088) | 4.40007710 |
| 20 | positive regulation of heat generation (GO:0031652) | 4.38628891 |
| 21 | nucleotide-sugar biosynthetic process (GO:0009226) | 4.30353725 |
| 22 | lysine metabolic process (GO:0006553) | 4.25772716 |
| 23 | lysine catabolic process (GO:0006554) | 4.25772716 |
| 24 | keratan sulfate catabolic process (GO:0042340) | 4.22485343 |
| 25 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.21383014 |
| 26 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.20822287 |
| 27 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.20411162 |
| 28 | regulation of glucocorticoid secretion (GO:2000849) | 4.14855820 |
| 29 | regulation of fever generation (GO:0031620) | 4.08608346 |
| 30 | exogenous drug catabolic process (GO:0042738) | 4.07040309 |
| 31 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.03705671 |
| 32 | * regulation of vitamin metabolic process (GO:0030656) | 4.00177122 |
| 33 | regulation of interferon-alpha production (GO:0032647) | 3.98548107 |
| 34 | cell aggregation (GO:0098743) | 3.98130460 |
| 35 | cartilage condensation (GO:0001502) | 3.98130460 |
| 36 | NIK/NF-kappaB signaling (GO:0038061) | 3.97686615 |
| 37 | oligosaccharide catabolic process (GO:0009313) | 3.94895835 |
| 38 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.94753151 |
| 39 | regulation of podosome assembly (GO:0071801) | 3.94335278 |
| 40 | quaternary ammonium group transport (GO:0015697) | 3.92321073 |
| 41 | membrane repolarization during action potential (GO:0086011) | 3.90395973 |
| 42 | hippo signaling (GO:0035329) | 3.89090018 |
| 43 | myeloid dendritic cell differentiation (GO:0043011) | 3.85969494 |
| 44 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.81334591 |
| 45 | branched-chain amino acid metabolic process (GO:0009081) | 3.81139165 |
| 46 | glycosphingolipid catabolic process (GO:0046479) | 3.80062545 |
| 47 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.78828468 |
| 48 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.77453989 |
| 49 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.72610842 |
| 50 | regulation of corticosteroid hormone secretion (GO:2000846) | 3.71375162 |
| 51 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.70582037 |
| 52 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.69833542 |
| 53 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.69287000 |
| 54 | drug catabolic process (GO:0042737) | 3.69241826 |
| 55 | carnitine metabolic process (GO:0009437) | 3.65029953 |
| 56 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.61356216 |
| 57 | regulation of mononuclear cell migration (GO:0071675) | 3.60505817 |
| 58 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.60317478 |
| 59 | dopamine biosynthetic process (GO:0042416) | 3.59272802 |
| 60 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.58280566 |
| 61 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.58280566 |
| 62 | regulation of chemokine biosynthetic process (GO:0045073) | 3.53556439 |
| 63 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.53323307 |
| 64 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.52090182 |
| 65 | mitotic G1/S transition checkpoint (GO:0044819) | 3.51782507 |
| 66 | response to protozoan (GO:0001562) | 3.51548067 |
| 67 | phosphate ion transmembrane transport (GO:0035435) | 3.50329550 |
| 68 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.50161153 |
| 69 | type I interferon signaling pathway (GO:0060337) | 3.49164587 |
| 70 | cellular response to type I interferon (GO:0071357) | 3.49164587 |
| 71 | macrophage activation involved in immune response (GO:0002281) | 3.48042410 |
| 72 | proline metabolic process (GO:0006560) | 3.47258872 |
| 73 | defense response to protozoan (GO:0042832) | 3.46461123 |
| 74 | regulation of T-helper cell differentiation (GO:0045622) | 3.44970148 |
| 75 | response to type I interferon (GO:0034340) | 3.43961570 |
| 76 | COPII vesicle coating (GO:0048208) | 3.42623549 |
| 77 | excretion (GO:0007588) | 3.41640535 |
| 78 | response to mercury ion (GO:0046689) | 3.41448028 |
| 79 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.40958811 |
| 80 | L-phenylalanine metabolic process (GO:0006558) | 3.40958811 |
| 81 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.40957164 |
| 82 | L-phenylalanine catabolic process (GO:0006559) | 3.39743325 |
| 83 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.39743325 |
| 84 | signal peptide processing (GO:0006465) | 3.39584970 |
| 85 | glycolipid catabolic process (GO:0019377) | 3.39278786 |
| 86 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.38745339 |
| 87 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.38703780 |
| 88 | tricarboxylic acid metabolic process (GO:0072350) | 3.38056570 |
| 89 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.36341857 |
| 90 | sequestering of metal ion (GO:0051238) | 3.35968894 |
| 91 | positive regulation of type 2 immune response (GO:0002830) | 3.35031972 |
| 92 | positive regulation of interleukin-17 production (GO:0032740) | 3.34384084 |
| 93 | positive regulation of defense response to virus by host (GO:0002230) | 3.32724902 |
| 94 | regulation of cardioblast differentiation (GO:0051890) | 3.32503109 |
| 95 | chondrocyte development (GO:0002063) | 3.31617484 |
| 96 | regulation of interleukin-12 production (GO:0032655) | 3.27083327 |
| 97 | regulation of heat generation (GO:0031650) | 3.26963992 |
| 98 | G1 DNA damage checkpoint (GO:0044783) | 3.26918924 |
| 99 | response to hepatocyte growth factor (GO:0035728) | 3.26508713 |
| 100 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.26508713 |
| 101 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.25622410 |
| 102 | protein heterotrimerization (GO:0070208) | 3.24664756 |
| 103 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.24575929 |
| 104 | positive regulation of interferon-alpha production (GO:0032727) | 3.24564124 |
| 105 | amino-acid betaine metabolic process (GO:0006577) | 3.23583458 |
| 106 | myeloid dendritic cell activation (GO:0001773) | 3.23297806 |
| 107 | aldehyde catabolic process (GO:0046185) | 3.22051874 |
| 108 | cellular response to lipopolysaccharide (GO:0071222) | 3.21763836 |
| 109 | positive regulation of steroid hormone secretion (GO:2000833) | 3.21640474 |
| 110 | branched-chain amino acid catabolic process (GO:0009083) | 3.21542661 |
| 111 | collagen fibril organization (GO:0030199) | 3.19571603 |
| 112 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.18815437 |
| 113 | COPI coating of Golgi vesicle (GO:0048205) | 3.18405998 |
| 114 | Golgi transport vesicle coating (GO:0048200) | 3.18405998 |
| 115 | regulation of cholesterol storage (GO:0010885) | 3.15841052 |
| 116 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.14805690 |
| 117 | positive regulation of tissue remodeling (GO:0034105) | 3.14698074 |
| 118 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.14669033 |
| 119 | germinal center formation (GO:0002467) | 3.12898183 |
| 120 | positive regulation of natural killer cell activation (GO:0032816) | 3.09782775 |
| 121 | cell volume homeostasis (GO:0006884) | 3.08936896 |
| 122 | regulation of immunoglobulin secretion (GO:0051023) | 3.08566194 |
| 123 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.08556945 |
| 124 | cellular response to molecule of bacterial origin (GO:0071219) | 3.08494628 |
| 125 | positive regulation of interleukin-10 production (GO:0032733) | 3.07404252 |
| 126 | immunoglobulin mediated immune response (GO:0016064) | 3.05995207 |
| 127 | dendritic cell differentiation (GO:0097028) | 3.02590701 |
| 128 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.01725352 |
| 129 | positive regulation of transcription factor import into nucleus (GO:0042993) | 3.00534205 |
| 130 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.00290313 |
| 131 | 4-hydroxyproline metabolic process (GO:0019471) | 2.99819010 |
| 132 | monocyte chemotaxis (GO:0002548) | 2.99092738 |
| 133 | positive regulation of interleukin-12 production (GO:0032735) | 2.98889339 |
| 134 | response to muramyl dipeptide (GO:0032495) | 2.98544523 |
| 135 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 2.97401158 |
| 136 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.97251518 |
| 137 | glutathione biosynthetic process (GO:0006750) | 2.96562842 |
| 138 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.96477391 |
| 139 | peptide hormone processing (GO:0016486) | 2.96448038 |
| 140 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.95782672 |
| 141 | vitamin transport (GO:0051180) | 2.95774592 |
| 142 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.95633672 |
| 143 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.95153802 |
| 144 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.95153391 |
| 145 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.94818747 |
| 146 | ceramide catabolic process (GO:0046514) | 2.94592337 |
| 147 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.92130859 |
| 148 | osteoclast differentiation (GO:0030316) | 2.91921470 |
| 149 | negative regulation of growth of symbiont in host (GO:0044130) | 2.91781040 |
| 150 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.91781040 |
| 151 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.91781040 |
| 152 | regulation of growth of symbiont in host (GO:0044126) | 2.91781040 |
| 153 | positive regulation of osteoclast differentiation (GO:0045672) | 2.90505783 |
| 154 | negative regulation of lipid storage (GO:0010888) | 2.89971668 |
| 155 | neurotransmitter catabolic process (GO:0042135) | 2.89563047 |
| 156 | gland morphogenesis (GO:0022612) | 2.88858436 |
| 157 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.88604897 |
| 158 | fatty acid beta-oxidation (GO:0006635) | 2.88472334 |
| 159 | positive regulation of interleukin-6 production (GO:0032755) | 2.87995708 |
| 160 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.87512734 |
| 161 | regulation of T-helper 1 type immune response (GO:0002825) | 2.86867702 |
| 162 | negative regulation of interleukin-17 production (GO:0032700) | 2.84071845 |
| 163 | eosinophil chemotaxis (GO:0048245) | 2.83755273 |
| 164 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.82649920 |
| 165 | negative regulation of interleukin-10 production (GO:0032693) | 2.82384761 |
| 166 | activation of MAPKKK activity (GO:0000185) | 2.81520009 |
| 167 | membrane lipid catabolic process (GO:0046466) | 2.81360563 |
| 168 | insulin secretion (GO:0030073) | 2.80965207 |
| 169 | regulation of activation of Janus kinase activity (GO:0010533) | 2.79856368 |
| 170 | renal absorption (GO:0070293) | 2.79594487 |
| 171 | * decidualization (GO:0046697) | 2.79206948 |
| 172 | metanephric nephron tubule development (GO:0072234) | 2.78634153 |
| 173 | metanephric tubule development (GO:0072170) | 2.78634153 |
| 174 | neutrophil activation involved in immune response (GO:0002283) | 2.77703901 |
| 175 | regulation of macrophage cytokine production (GO:0010935) | 2.76523432 |
| 176 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.75924178 |
| 177 | 2-oxoglutarate metabolic process (GO:0006103) | 2.75453066 |
| 178 | sulfur compound catabolic process (GO:0044273) | 2.75230549 |
| 179 | aromatic amino acid family catabolic process (GO:0009074) | 2.74428103 |
| 180 | glyoxylate metabolic process (GO:0046487) | 2.73909487 |
| 181 | tryptophan metabolic process (GO:0006568) | 2.73382111 |
| 182 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.72480004 |
| 183 | homocysteine metabolic process (GO:0050667) | 2.70890800 |
| 184 | toxin transport (GO:1901998) | 2.68936754 |
| 185 | response to lead ion (GO:0010288) | 2.66997849 |
| 186 | proline biosynthetic process (GO:0006561) | 2.66601180 |
| 187 | L-fucose catabolic process (GO:0042355) | 2.66133414 |
| 188 | fucose catabolic process (GO:0019317) | 2.66133414 |
| 189 | L-fucose metabolic process (GO:0042354) | 2.66133414 |
| 190 | glucuronate metabolic process (GO:0019585) | 2.66114336 |
| 191 | uronic acid metabolic process (GO:0006063) | 2.66114336 |
| 192 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.65967736 |
| 193 | peptide hormone secretion (GO:0030072) | 2.65869123 |
| 194 | positive regulation of vesicle fusion (GO:0031340) | 2.64085682 |
| 195 | catechol-containing compound biosynthetic process (GO:0009713) | 2.63567710 |
| 196 | catecholamine biosynthetic process (GO:0042423) | 2.63567710 |
| 197 | metanephric nephron epithelium development (GO:0072243) | 2.60007816 |
| 198 | cellular response to vitamin D (GO:0071305) | 2.59525712 |
| 199 | cyclic nucleotide catabolic process (GO:0009214) | 2.59456108 |
| 200 | fatty acid oxidation (GO:0019395) | 2.58886039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.06430822 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 4.76397323 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.47826433 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.05777691 |
| 5 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.75137443 |
| 6 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.73970562 |
| 7 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 3.64907287 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.62664266 |
| 9 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.48826594 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.35928115 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.06195856 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.03989336 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.95464079 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.93999669 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.88062851 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83656785 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81737056 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.78059266 |
| 19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.75178703 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.62167755 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.43872199 |
| 22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.39078459 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.38891943 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.38696351 |
| 25 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.30041023 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.28887201 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.22380829 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.09799820 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.07015540 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.05715695 |
| 31 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.05668008 |
| 32 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.03571195 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96605319 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91130547 |
| 35 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90223152 |
| 36 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.87281319 |
| 37 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.86485183 |
| 38 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.83295016 |
| 39 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.77654664 |
| 40 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.77179502 |
| 41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.74899148 |
| 42 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.74223650 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.73878456 |
| 44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.71849358 |
| 45 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.69587011 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.69077037 |
| 47 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.68451209 |
| 48 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.67311750 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64734342 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63784042 |
| 51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.62225789 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59454246 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.59300793 |
| 54 | CJUN_26792858_Chip-Seq_BT549_Human | 1.57369123 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.57179209 |
| 56 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.56824585 |
| 57 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.55829697 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55655497 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.55036245 |
| 60 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.54340629 |
| 61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54189047 |
| 62 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.54154511 |
| 63 | MYC_22102868_ChIP-Seq_BL_Human | 1.54065234 |
| 64 | * MAF_26560356_Chip-Seq_TH1_Human | 1.50333036 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49160025 |
| 66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45927795 |
| 67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44105852 |
| 68 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.40348376 |
| 69 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40275660 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34614123 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32671708 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.31970559 |
| 73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31630433 |
| 74 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.30679228 |
| 75 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30400036 |
| 76 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29728350 |
| 77 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29514204 |
| 78 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28742495 |
| 79 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.28060317 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26898164 |
| 81 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26859448 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26823662 |
| 83 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25819689 |
| 84 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.24932381 |
| 85 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23605920 |
| 86 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.23532587 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22239573 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21221070 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20945165 |
| 90 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19711717 |
| 91 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19416931 |
| 92 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.18433301 |
| 93 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.17808879 |
| 94 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.17808879 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17568713 |
| 96 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.17228190 |
| 97 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.17228190 |
| 98 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.17057064 |
| 99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14917123 |
| 100 | * MAF_26560356_Chip-Seq_TH2_Human | 1.14914311 |
| 101 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13187458 |
| 102 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12645646 |
| 103 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11479694 |
| 104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11038538 |
| 105 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.10894436 |
| 106 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.10312893 |
| 107 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09406094 |
| 108 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.09192843 |
| 109 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.08912308 |
| 110 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.08205725 |
| 111 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08185303 |
| 112 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.07999179 |
| 113 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07949296 |
| 114 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07689169 |
| 115 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07650022 |
| 116 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07649881 |
| 117 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07636085 |
| 118 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06908203 |
| 119 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06542207 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05954311 |
| 121 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.05658329 |
| 122 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05259505 |
| 123 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03940096 |
| 124 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03686529 |
| 125 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.03450944 |
| 126 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.02643102 |
| 127 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02501726 |
| 128 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02176441 |
| 129 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.01911864 |
| 130 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.01534388 |
| 131 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.01518242 |
| 132 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.01464843 |
| 133 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01089957 |
| 134 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00467533 |
| 135 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00446637 |
| 136 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.00369810 |
| 137 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.00117627 |
| 138 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.99709683 |
| 139 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.99272168 |
| 140 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98527646 |
| 141 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98359898 |
| 142 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98300026 |
| 143 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98146353 |
| 144 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.98095950 |
| 145 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.98092558 |
| 146 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.97888134 |
| 147 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96411259 |
| 148 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96224276 |
| 149 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.95553183 |
| 150 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95416695 |
| 151 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95125316 |
| 152 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94516633 |
| 153 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94384357 |
| 154 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.94155787 |
| 155 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93379498 |
| 156 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.92604344 |
| 157 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92358895 |
| 158 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91832450 |
| 159 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91461620 |
| 160 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.90246133 |
| 161 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89209553 |
| 162 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89111646 |
| 163 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.89022516 |
| 164 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89020759 |
| 165 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.88547823 |
| 166 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.88547169 |
| 167 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88201190 |
| 168 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87904411 |
| 169 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.87442687 |
| 170 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.85008756 |
| 171 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.83951824 |
| 172 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.83313768 |
| 173 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.83205275 |
| 174 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.82190872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 5.30377998 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.87316124 |
| 3 | MP0004043_abnormal_pH_regulation | 4.83192010 |
| 4 | MP0005360_urolithiasis | 4.29616315 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 3.68600838 |
| 6 | MP0003195_calcinosis | 3.62510354 |
| 7 | MP0003252_abnormal_bile_duct | 3.56972234 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 3.45530699 |
| 9 | MP0005058_abnormal_lysosome_morphology | 3.41594765 |
| 10 | MP0009785_altered_susceptibility_to | 3.32476120 |
| 11 | MP0005503_abnormal_tendon_morphology | 3.15624590 |
| 12 | MP0003436_decreased_susceptibility_to | 3.08417997 |
| 13 | MP0005451_abnormal_body_composition | 2.97150290 |
| 14 | MP0006082_CNS_inflammation | 2.95114375 |
| 15 | MP0004510_myositis | 2.90573209 |
| 16 | MP0009840_abnormal_foam_cell | 2.86949111 |
| 17 | MP0005332_abnormal_amino_acid | 2.82029226 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.74601074 |
| 19 | * MP0001765_abnormal_ion_homeostasis | 2.72738068 |
| 20 | MP0003453_abnormal_keratinocyte_physiol | 2.63717412 |
| 21 | MP0003724_increased_susceptibility_to | 2.59208893 |
| 22 | MP0001835_abnormal_antigen_presentation | 2.45744188 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.41253500 |
| 24 | MP0002928_abnormal_bile_duct | 2.38517008 |
| 25 | MP0001790_abnormal_immune_system | 2.37700437 |
| 26 | MP0005387_immune_system_phenotype | 2.37700437 |
| 27 | MP0009278_abnormal_bone_marrow | 2.35451759 |
| 28 | * MP0009643_abnormal_urine_homeostasis | 2.33880696 |
| 29 | MP0008875_abnormal_xenobiotic_pharmacok | 2.30338076 |
| 30 | MP0002419_abnormal_innate_immunity | 2.25871194 |
| 31 | MP0002933_joint_inflammation | 2.25772650 |
| 32 | MP0004947_skin_inflammation | 2.23314790 |
| 33 | MP0005025_abnormal_response_to | 2.22519748 |
| 34 | MP0001756_abnormal_urination | 2.21528647 |
| 35 | MP0005671_abnormal_response_to | 2.16750579 |
| 36 | MP0003283_abnormal_digestive_organ | 2.10785541 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 2.10408058 |
| 38 | MP0000343_altered_response_to | 2.06878476 |
| 39 | MP0005275_abnormal_skin_tensile | 2.04318381 |
| 40 | MP0009764_decreased_sensitivity_to | 2.03352511 |
| 41 | * MP0005636_abnormal_mineral_homeostasis | 1.98514570 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.97169551 |
| 43 | MP0001853_heart_inflammation | 1.97064821 |
| 44 | MP0004019_abnormal_vitamin_homeostasis | 1.94941145 |
| 45 | MP0002877_abnormal_melanocyte_morpholog | 1.90956096 |
| 46 | MP0001958_emphysema | 1.89719455 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.89300463 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.88938579 |
| 49 | MP0004885_abnormal_endolymph | 1.81659696 |
| 50 | MP0003329_amyloid_beta_deposits | 1.81310277 |
| 51 | * MP0002896_abnormal_bone_mineralization | 1.78514814 |
| 52 | MP0002723_abnormal_immune_serum | 1.76714379 |
| 53 | MP0003448_altered_tumor_morphology | 1.74364738 |
| 54 | MP0001944_abnormal_pancreas_morphology | 1.71260316 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.70413922 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.70413922 |
| 57 | MP0003879_abnormal_hair_cell | 1.67860988 |
| 58 | MP0002136_abnormal_kidney_physiology | 1.66940612 |
| 59 | MP0005220_abnormal_exocrine_pancreas | 1.66678207 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.65940292 |
| 61 | MP0002909_abnormal_adrenal_gland | 1.64575838 |
| 62 | MP0001800_abnormal_humoral_immune | 1.63235326 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.62041822 |
| 64 | MP0002089_abnormal_postnatal_growth/wei | 1.61325301 |
| 65 | MP0002332_abnormal_exercise_endurance | 1.59618052 |
| 66 | MP0008004_abnormal_stomach_pH | 1.53570494 |
| 67 | MP0000858_altered_metastatic_potential | 1.51837911 |
| 68 | MP0004264_abnormal_extraembryonic_tissu | 1.49711912 |
| 69 | MP0000013_abnormal_adipose_tissue | 1.47460693 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.46284937 |
| 71 | MP0004272_abnormal_basement_membrane | 1.45055678 |
| 72 | * MP0008469_abnormal_protein_level | 1.44659857 |
| 73 | MP0002405_respiratory_system_inflammati | 1.41996747 |
| 74 | MP0001819_abnormal_immune_cell | 1.41511510 |
| 75 | MP0002254_reproductive_system_inflammat | 1.40394942 |
| 76 | * MP0000163_abnormal_cartilage_morphology | 1.39819187 |
| 77 | MP0002420_abnormal_adaptive_immunity | 1.39133911 |
| 78 | MP0005166_decreased_susceptibility_to | 1.38187258 |
| 79 | MP0000685_abnormal_immune_system | 1.35500932 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 1.35259110 |
| 81 | * MP0002115_abnormal_skeleton_extremities | 1.31937772 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.30836813 |
| 83 | MP0005508_abnormal_skeleton_morphology | 1.30281602 |
| 84 | MP0006054_spinal_hemorrhage | 1.30077859 |
| 85 | MP0001299_abnormal_eye_distance/ | 1.29954825 |
| 86 | MP0001270_distended_abdomen | 1.28557109 |
| 87 | MP0002876_abnormal_thyroid_physiology | 1.26944210 |
| 88 | MP0002282_abnormal_trachea_morphology | 1.24743468 |
| 89 | MP0003091_abnormal_cell_migration | 1.23875069 |
| 90 | MP0003646_muscle_fatigue | 1.23403494 |
| 91 | MP0002295_abnormal_pulmonary_circulatio | 1.19206541 |
| 92 | MP0003300_gastrointestinal_ulcer | 1.15956695 |
| 93 | * MP0001216_abnormal_epidermal_layer | 1.15617797 |
| 94 | MP0008961_abnormal_basal_metabolism | 1.15031384 |
| 95 | MP0005164_abnormal_response_to | 1.12460163 |
| 96 | MP0000604_amyloidosis | 1.10708602 |
| 97 | MP0002108_abnormal_muscle_morphology | 1.09591015 |
| 98 | MP0005310_abnormal_salivary_gland | 1.08009212 |
| 99 | MP0009250_abnormal_appendicular_skeleto | 1.02705706 |
| 100 | MP0008260_abnormal_autophagy | 1.02236857 |
| 101 | MP0000003_abnormal_adipose_tissue | 1.01860734 |
| 102 | MP0004808_abnormal_hematopoietic_stem | 1.00498843 |
| 103 | MP0003566_abnormal_cell_adhesion | 1.00187806 |
| 104 | MP0000920_abnormal_myelination | 0.97088737 |
| 105 | MP0000747_muscle_weakness | 0.96622818 |
| 106 | MP0010234_abnormal_vibrissa_follicle | 0.96342243 |
| 107 | * MP0000716_abnormal_immune_system | 0.96326605 |
| 108 | * MP0002113_abnormal_skeleton_development | 0.94318361 |
| 109 | MP0009763_increased_sensitivity_to | 0.93841666 |
| 110 | MP0001727_abnormal_embryo_implantation | 0.93641858 |
| 111 | MP0001664_abnormal_digestion | 0.93415227 |
| 112 | MP0005076_abnormal_cell_differentiation | 0.93245665 |
| 113 | MP0000538_abnormal_urinary_bladder | 0.93114583 |
| 114 | MP0001849_ear_inflammation | 0.93067352 |
| 115 | MP0000230_abnormal_systemic_arterial | 0.92601947 |
| 116 | MP0005464_abnormal_platelet_physiology | 0.91304871 |
| 117 | MP0004134_abnormal_chest_morphology | 0.90660662 |
| 118 | MP0000579_abnormal_nail_morphology | 0.90304801 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.90238976 |
| 120 | MP0005390_skeleton_phenotype | 0.90192653 |
| 121 | MP0002168_other_aberrant_phenotype | 0.89877460 |
| 122 | MP0001177_atelectasis | 0.89597956 |
| 123 | MP0001533_abnormal_skeleton_physiology | 0.87237561 |
| 124 | MP0004883_abnormal_blood_vessel | 0.86863759 |
| 125 | MP0002693_abnormal_pancreas_physiology | 0.86339959 |
| 126 | MP0005165_increased_susceptibility_to | 0.84459820 |
| 127 | MP0004084_abnormal_cardiac_muscle | 0.83970807 |
| 128 | * MP0003795_abnormal_bone_structure | 0.83627147 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.83345092 |
| 130 | MP0008874_decreased_physiological_sensi | 0.82081706 |
| 131 | MP0000681_abnormal_thyroid_gland | 0.81688518 |
| 132 | MP0005023_abnormal_wound_healing | 0.81500131 |
| 133 | MP0002998_abnormal_bone_remodeling | 0.81140488 |
| 134 | MP0005365_abnormal_bile_salt | 0.79665967 |
| 135 | MP0002837_dystrophic_cardiac_calcinosis | 0.79354021 |
| 136 | MP0009333_abnormal_splenocyte_physiolog | 0.78668973 |
| 137 | MP0005171_absent_coat_pigmentation | 0.78419256 |
| 138 | * MP0003953_abnormal_hormone_level | 0.77572251 |
| 139 | MP0005408_hypopigmentation | 0.77430222 |
| 140 | MP0000762_abnormal_tongue_morphology | 0.77238461 |
| 141 | MP0003705_abnormal_hypodermis_morpholog | 0.77096027 |
| 142 | MP0002398_abnormal_bone_marrow | 0.77090603 |
| 143 | MP0005647_abnormal_sex_gland | 0.76579863 |
| 144 | MP0010307_abnormal_tumor_latency | 0.76349499 |
| 145 | * MP0002429_abnormal_blood_cell | 0.75823386 |
| 146 | MP0003690_abnormal_glial_cell | 0.75254907 |
| 147 | MP0003075_altered_response_to | 0.75232408 |
| 148 | MP0001542_abnormal_bone_strength | 0.71242876 |
| 149 | MP0001963_abnormal_hearing_physiology | 0.70974215 |
| 150 | MP0005666_abnormal_adipose_tissue | 0.69282106 |
| 151 | MP0003878_abnormal_ear_physiology | 0.68606350 |
| 152 | MP0005377_hearing/vestibular/ear_phenot | 0.68606350 |
| 153 | MP0004742_abnormal_vestibular_system | 0.68440002 |
| 154 | MP0000467_abnormal_esophagus_morphology | 0.68286972 |
| 155 | MP0000613_abnormal_salivary_gland | 0.66490208 |
| 156 | MP0000733_abnormal_muscle_development | 0.66372173 |
| 157 | MP0001485_abnormal_pinna_reflex | 0.66167253 |
| 158 | MP0000428_abnormal_craniofacial_morphol | 0.65864772 |
| 159 | MP0010352_gastrointestinal_tract_polyps | 0.65486452 |
| 160 | MP0004185_abnormal_adipocyte_glucose | 0.64159450 |
| 161 | MP0004484_altered_response_of | 0.64088877 |
| 162 | MP0003941_abnormal_skin_development | 0.64019199 |
| 163 | MP0001191_abnormal_skin_condition | 0.63544883 |
| 164 | MP0004859_abnormal_synaptic_plasticity | 0.62317512 |
| 165 | MP0000371_diluted_coat_color | 0.61427382 |
| 166 | MP0000249_abnormal_blood_vessel | 0.61351054 |
| 167 | MP0002118_abnormal_lipid_homeostasis | 0.60496011 |
| 168 | MP0002060_abnormal_skin_morphology | 0.60166516 |
| 169 | MP0004233_abnormal_muscle_weight | 0.59387808 |
| 170 | MP0004270_analgesia | 0.58713554 |
| 171 | MP0005257_abnormal_intraocular_pressure | 0.58458096 |
| 172 | MP0010678_abnormal_skin_adnexa | 0.57289773 |
| 173 | MP0000689_abnormal_spleen_morphology | 0.55769484 |
| 174 | * MP0002722_abnormal_immune_system | 0.55616731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.25378770 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.25378770 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.25378770 |
| 4 | Polydipsia (HP:0001959) | 6.16500483 |
| 5 | Abnormal drinking behavior (HP:0030082) | 6.16500483 |
| 6 | Polyuria (HP:0000103) | 5.64056586 |
| 7 | Abnormal urine output (HP:0012590) | 5.20745306 |
| 8 | Severe visual impairment (HP:0001141) | 4.95615364 |
| 9 | Tubular atrophy (HP:0000092) | 4.91241927 |
| 10 | Epiphyseal dysplasia (HP:0002656) | 4.71911433 |
| 11 | Abnormality of renal excretion (HP:0011036) | 4.70151522 |
| 12 | Tubulointerstitial fibrosis (HP:0005576) | 4.69281302 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 4.62015555 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.50544779 |
| 15 | Metabolic alkalosis (HP:0200114) | 4.40203471 |
| 16 | * Delayed epiphyseal ossification (HP:0002663) | 4.36126543 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 4.26665099 |
| 18 | Cervical subluxation (HP:0003308) | 4.21199910 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 4.18994834 |
| 20 | Abnormal tarsal ossification (HP:0008369) | 4.17605577 |
| 21 | Dysostosis multiplex (HP:0000943) | 4.16670615 |
| 22 | Irregular epiphyses (HP:0010582) | 4.11732326 |
| 23 | Loss of speech (HP:0002371) | 4.10634725 |
| 24 | Increased circulating renin level (HP:0000848) | 3.99290335 |
| 25 | Hypoplastic ischia (HP:0003175) | 3.93243745 |
| 26 | Vitreoretinal degeneration (HP:0000655) | 3.92848969 |
| 27 | Systemic lupus erythematosus (HP:0002725) | 3.85449911 |
| 28 | Disinhibition (HP:0000734) | 3.79451713 |
| 29 | Orchitis (HP:0100796) | 3.78488404 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 3.76063581 |
| 31 | Optic neuritis (HP:0100653) | 3.76063581 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 3.69612153 |
| 33 | Gout (HP:0001997) | 3.67825501 |
| 34 | Hypokalemic alkalosis (HP:0001949) | 3.55560700 |
| 35 | Nuclear cataract (HP:0100018) | 3.55122000 |
| 36 | Recurrent abscess formation (HP:0002722) | 3.51682982 |
| 37 | Neurofibrillary tangles (HP:0002185) | 3.49127356 |
| 38 | Flat capital femoral epiphysis (HP:0003370) | 3.48614504 |
| 39 | Proximal tubulopathy (HP:0000114) | 3.48254928 |
| 40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.47917031 |
| 41 | Metaphyseal cupping (HP:0003021) | 3.46152048 |
| 42 | Abnormality of the ischium (HP:0003174) | 3.45083737 |
| 43 | Cupped ribs (HP:0000887) | 3.43312827 |
| 44 | Eczematoid dermatitis (HP:0000976) | 3.42233628 |
| 45 | Hyperactive renin-angiotensin system (HP:0000841) | 3.34434524 |
| 46 | * Protuberant abdomen (HP:0001538) | 3.33084201 |
| 47 | Neonatal short-limb short stature (HP:0008921) | 3.32424560 |
| 48 | Stomatitis (HP:0010280) | 3.26427596 |
| 49 | * Generalized aminoaciduria (HP:0002909) | 3.25306088 |
| 50 | Mutism (HP:0002300) | 3.24766510 |
| 51 | Interstitial pulmonary disease (HP:0006530) | 3.22517554 |
| 52 | Axonal loss (HP:0003447) | 3.22371396 |
| 53 | Myositis (HP:0100614) | 3.21841595 |
| 54 | Tubulointerstitial abnormality (HP:0001969) | 3.19997686 |
| 55 | Abnormal foot bone ossification (HP:0010675) | 3.18508909 |
| 56 | Small epiphyses (HP:0010585) | 3.17443365 |
| 57 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.17349444 |
| 58 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.17349444 |
| 59 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.17349444 |
| 60 | Hypomagnesemia (HP:0002917) | 3.15763656 |
| 61 | Mediastinal lymphadenopathy (HP:0100721) | 3.14702178 |
| 62 | Arterial tortuosity (HP:0005116) | 3.14679841 |
| 63 | Amblyopia (HP:0000646) | 3.06319720 |
| 64 | Abnormality of renin-angiotensin system (HP:0000847) | 3.05959227 |
| 65 | Mucopolysacchariduria (HP:0008155) | 3.05105792 |
| 66 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.05105792 |
| 67 | Increased serum ferritin (HP:0003281) | 3.04634952 |
| 68 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 3.03271837 |
| 69 | Flat acetabular roof (HP:0003180) | 3.00624036 |
| 70 | Thick nail (HP:0001805) | 2.93644596 |
| 71 | Myocardial infarction (HP:0001658) | 2.93340899 |
| 72 | Abnormality of chloride homeostasis (HP:0011422) | 2.92412808 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.90905883 |
| 74 | Cerebral inclusion bodies (HP:0100314) | 2.88551618 |
| 75 | Vascular tortuosity (HP:0004948) | 2.87700346 |
| 76 | Apathy (HP:0000741) | 2.84636897 |
| 77 | Abnormality of purine metabolism (HP:0004352) | 2.77529357 |
| 78 | Hip contracture (HP:0003273) | 2.77527065 |
| 79 | Hypokalemia (HP:0002900) | 2.77334138 |
| 80 | Alkalosis (HP:0001948) | 2.76672887 |
| 81 | Abnormality of magnesium homeostasis (HP:0004921) | 2.76671567 |
| 82 | Diminished motivation (HP:0000745) | 2.76272120 |
| 83 | Abnormality of the renal cortex (HP:0011035) | 2.75142658 |
| 84 | Increased IgM level (HP:0003496) | 2.72204564 |
| 85 | Gangrene (HP:0100758) | 2.62304881 |
| 86 | Keratoconjunctivitis (HP:0001096) | 2.60052983 |
| 87 | Parakeratosis (HP:0001036) | 2.58682897 |
| 88 | Renal salt wasting (HP:0000127) | 2.54674572 |
| 89 | Increased purine levels (HP:0004368) | 2.53765654 |
| 90 | Hyperuricemia (HP:0002149) | 2.53765654 |
| 91 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.53431215 |
| 92 | Gastrointestinal infarctions (HP:0005244) | 2.47726637 |
| 93 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.46634070 |
| 94 | Abnormality of carpal bone ossification (HP:0006257) | 2.42731872 |
| 95 | * Metaphyseal irregularity (HP:0003025) | 2.42550125 |
| 96 | Hemoptysis (HP:0002105) | 2.38100653 |
| 97 | Progressive neurologic deterioration (HP:0002344) | 2.37134317 |
| 98 | Glomerulonephritis (HP:0000099) | 2.36966776 |
| 99 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.35889097 |
| 100 | Vertebral hypoplasia (HP:0008417) | 2.35889097 |
| 101 | Limited hip movement (HP:0008800) | 2.34624701 |
| 102 | Hypertensive crisis (HP:0100735) | 2.33196518 |
| 103 | Abnormal vertebral ossification (HP:0100569) | 2.31854841 |
| 104 | Milia (HP:0001056) | 2.31825786 |
| 105 | Neuronal loss in central nervous system (HP:0002529) | 2.28793195 |
| 106 | Decreased circulating renin level (HP:0003351) | 2.28644226 |
| 107 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.26840718 |
| 108 | Upper motor neuron abnormality (HP:0002127) | 2.26771504 |
| 109 | Hematochezia (HP:0002573) | 2.25758078 |
| 110 | Recurrent viral infections (HP:0004429) | 2.24973794 |
| 111 | Arthropathy (HP:0003040) | 2.22666150 |
| 112 | Plantar hyperkeratosis (HP:0007556) | 2.21136789 |
| 113 | Osteoarthritis (HP:0002758) | 2.20088466 |
| 114 | Abnormal ossification of hand bones (HP:0005921) | 2.19455352 |
| 115 | Abnormality of iron homeostasis (HP:0011031) | 2.18897317 |
| 116 | Purpura (HP:0000979) | 2.17148878 |
| 117 | Flattened epiphyses (HP:0003071) | 2.16430616 |
| 118 | Nausea (HP:0002018) | 2.15624301 |
| 119 | Vasculitis (HP:0002633) | 2.13552092 |
| 120 | Prolonged neonatal jaundice (HP:0006579) | 2.11950949 |
| 121 | Genu varum (HP:0002970) | 2.10876135 |
| 122 | Poor head control (HP:0002421) | 2.09639014 |
| 123 | Abnormality of nail color (HP:0100643) | 2.09042758 |
| 124 | Abnormality of femoral epiphyses (HP:0006499) | 2.08389913 |
| 125 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.08389913 |
| 126 | Amyloidosis (HP:0011034) | 2.08362754 |
| 127 | Beaking of vertebral bodies (HP:0004568) | 2.07913158 |
| 128 | Abnormal hand bone ossification (HP:0010660) | 2.07177117 |
| 129 | Inappropriate behavior (HP:0000719) | 2.06889475 |
| 130 | Abnormality of nucleobase metabolism (HP:0010932) | 2.06452009 |
| 131 | Anorexia (HP:0002039) | 2.05639915 |
| 132 | Hepatosplenomegaly (HP:0001433) | 2.04923031 |
| 133 | Recurrent skin infections (HP:0001581) | 2.03838744 |
| 134 | Abnormality of potassium homeostasis (HP:0011042) | 2.02853701 |
| 135 | Agnosia (HP:0010524) | 2.02699163 |
| 136 | Pulmonary infiltrates (HP:0002113) | 2.02676126 |
| 137 | Hyperaldosteronism (HP:0000859) | 2.01956165 |
| 138 | Personality changes (HP:0000751) | 2.01666408 |
| 139 | Onycholysis (HP:0001806) | 2.00627282 |
| 140 | Amaurosis fugax (HP:0100576) | 1.99974901 |
| 141 | Ketoacidosis (HP:0001993) | 1.99250743 |
| 142 | Dementia (HP:0000726) | 1.99166050 |
| 143 | Asymmetric septal hypertrophy (HP:0001670) | 1.96559655 |
| 144 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.96281367 |
| 145 | Hyperphosphaturia (HP:0003109) | 1.96128140 |
| 146 | Premature loss of primary teeth (HP:0006323) | 1.95815042 |
| 147 | Late onset (HP:0003584) | 1.94733725 |
| 148 | Ulnar bowing (HP:0003031) | 1.93720215 |
| 149 | * Abdominal distention (HP:0003270) | 1.93207339 |
| 150 | Stage 5 chronic kidney disease (HP:0003774) | 1.93033167 |
| 151 | Petechiae (HP:0000967) | 1.92765965 |
| 152 | Fused cervical vertebrae (HP:0002949) | 1.91960759 |
| 153 | Recurrent fungal infections (HP:0002841) | 1.91451795 |
| 154 | Abnormal blistering of the skin (HP:0008066) | 1.89889624 |
| 155 | Hand muscle atrophy (HP:0009130) | 1.89726968 |
| 156 | Abnormality of the vertebral endplates (HP:0005106) | 1.89468548 |
| 157 | Coxa vara (HP:0002812) | 1.89406948 |
| 158 | Hypergammaglobulinemia (HP:0010702) | 1.89309842 |
| 159 | Aortic dissection (HP:0002647) | 1.89220425 |
| 160 | Gingivitis (HP:0000230) | 1.89043944 |
| 161 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.88755858 |
| 162 | Malnutrition (HP:0004395) | 1.88669998 |
| 163 | Ankle contracture (HP:0006466) | 1.88215026 |
| 164 | Hypoplasia of the odontoid process (HP:0003311) | 1.87909353 |
| 165 | Autoimmune hemolytic anemia (HP:0001890) | 1.87747496 |
| 166 | Basal ganglia calcification (HP:0002135) | 1.87692994 |
| 167 | Ridged nail (HP:0001807) | 1.87418107 |
| 168 | Spondylolisthesis (HP:0003302) | 1.86659107 |
| 169 | Polyneuropathy (HP:0001271) | 1.86485767 |
| 170 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.85968258 |
| 171 | Chronic obstructive pulmonary disease (HP:0006510) | 1.85337480 |
| 172 | Obstructive lung disease (HP:0006536) | 1.85337480 |
| 173 | Glycosuria (HP:0003076) | 1.84632700 |
| 174 | Abnormality of urine glucose concentration (HP:0011016) | 1.84632700 |
| 175 | * Bone pain (HP:0002653) | 1.84391751 |
| 176 | Short femoral neck (HP:0100864) | 1.83344668 |
| 177 | Neoplasm of head and neck (HP:0012288) | 1.82325539 |
| 178 | Esophageal neoplasm (HP:0100751) | 1.82325539 |
| 179 | Disproportionate short-trunk short stature (HP:0003521) | 1.81901693 |
| 180 | Mild short stature (HP:0003502) | 1.81863462 |
| 181 | Thoracic kyphosis (HP:0002942) | 1.81167029 |
| 182 | T lymphocytopenia (HP:0005403) | 1.80733700 |
| 183 | Alopecia of scalp (HP:0002293) | 1.79603045 |
| 184 | Nail dystrophy (HP:0008404) | 1.77650720 |
| 185 | Renal tubular acidosis (HP:0001947) | 1.77613318 |
| 186 | Pathologic fracture (HP:0002756) | 1.74833826 |
| 187 | Platyspondyly (HP:0000926) | 1.74442841 |
| 188 | Thoracolumbar scoliosis (HP:0002944) | 1.73774156 |
| 189 | Nonimmune hydrops fetalis (HP:0001790) | 1.72264728 |
| 190 | Ovoid vertebral bodies (HP:0003300) | 1.71859436 |
| 191 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.71770299 |
| 192 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.70924663 |
| 193 | Absent frontal sinuses (HP:0002688) | 1.70430943 |
| 194 | Irregular vertebral endplates (HP:0003301) | 1.68528366 |
| 195 | Muscle fiber splitting (HP:0003555) | 1.67990438 |
| 196 | Protrusio acetabuli (HP:0003179) | 1.67950882 |
| 197 | Mitral valve prolapse (HP:0001634) | 1.67351404 |
| 198 | Ulnar deviation of the wrist (HP:0003049) | 1.67284406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 8.86974352 |
| 2 | IRAK3 | 5.75857286 |
| 3 | NME2 | 4.76163387 |
| 4 | WNK4 | 3.94690985 |
| 5 | OXSR1 | 3.72343319 |
| 6 | SIK2 | 3.61350411 |
| 7 | MAP3K14 | 3.26018056 |
| 8 | PRKD3 | 3.25327945 |
| 9 | INSRR | 3.01726276 |
| 10 | TAOK2 | 2.96676518 |
| 11 | GRK7 | 2.92759932 |
| 12 | WNK3 | 2.88652250 |
| 13 | PIM2 | 2.70549501 |
| 14 | MOS | 2.54331891 |
| 15 | MAP3K3 | 2.44735056 |
| 16 | RIPK1 | 2.42755004 |
| 17 | TBK1 | 2.35651910 |
| 18 | NME1 | 2.33302335 |
| 19 | FRK | 2.31054628 |
| 20 | MET | 2.30618964 |
| 21 | MATK | 2.27610383 |
| 22 | STK39 | 2.13721709 |
| 23 | IRAK4 | 2.02240517 |
| 24 | IKBKB | 1.98634379 |
| 25 | TYK2 | 1.92751645 |
| 26 | PTK6 | 1.92674760 |
| 27 | DDR2 | 1.89781460 |
| 28 | FGR | 1.89718873 |
| 29 | MST4 | 1.79824932 |
| 30 | BLK | 1.75439334 |
| 31 | LATS2 | 1.74567632 |
| 32 | IKBKE | 1.66925558 |
| 33 | EPHA4 | 1.56887052 |
| 34 | RIPK4 | 1.51242440 |
| 35 | JAK3 | 1.45372611 |
| 36 | ARAF | 1.40942362 |
| 37 | TRIB3 | 1.39223503 |
| 38 | MAP3K13 | 1.37924752 |
| 39 | STK38L | 1.29704035 |
| 40 | PRKD2 | 1.26149265 |
| 41 | CHUK | 1.25671108 |
| 42 | PAK4 | 1.19437884 |
| 43 | MAP2K3 | 1.15709477 |
| 44 | BCKDK | 1.14912441 |
| 45 | PRKCH | 1.12211399 |
| 46 | EPHB1 | 1.09477039 |
| 47 | NEK2 | 1.09311897 |
| 48 | ABL2 | 1.08007223 |
| 49 | MAP3K2 | 1.07569395 |
| 50 | SIK1 | 1.06307475 |
| 51 | IRAK2 | 1.04667231 |
| 52 | NEK6 | 0.99646924 |
| 53 | ICK | 0.97152979 |
| 54 | PDK2 | 0.97141109 |
| 55 | ITK | 0.97140623 |
| 56 | ERN1 | 0.96675961 |
| 57 | PTK2 | 0.94512589 |
| 58 | ZAP70 | 0.94485579 |
| 59 | STK10 | 0.94373883 |
| 60 | SGK494 | 0.94201144 |
| 61 | SGK223 | 0.94201144 |
| 62 | MAP4K1 | 0.94144835 |
| 63 | CLK1 | 0.92363095 |
| 64 | TTN | 0.89441387 |
| 65 | MAPK15 | 0.88429864 |
| 66 | TESK2 | 0.86822221 |
| 67 | EPHA2 | 0.86619490 |
| 68 | PIK3CG | 0.85607541 |
| 69 | MKNK2 | 0.84729612 |
| 70 | JAK1 | 0.84257269 |
| 71 | LATS1 | 0.83861441 |
| 72 | MAP3K5 | 0.81330463 |
| 73 | WNK1 | 0.80787709 |
| 74 | ADRBK2 | 0.80141069 |
| 75 | ERBB3 | 0.77948990 |
| 76 | MAP3K9 | 0.74845500 |
| 77 | MAP3K7 | 0.74022096 |
| 78 | CDC42BPA | 0.72691367 |
| 79 | CSF1R | 0.71490295 |
| 80 | MAP3K10 | 0.71486319 |
| 81 | NTRK1 | 0.71265214 |
| 82 | IRAK1 | 0.71226564 |
| 83 | GSK3A | 0.71179463 |
| 84 | NEK9 | 0.69234276 |
| 85 | BCR | 0.66065626 |
| 86 | SIK3 | 0.64772634 |
| 87 | PASK | 0.64539044 |
| 88 | MAP3K8 | 0.62080207 |
| 89 | LYN | 0.60739946 |
| 90 | PTK2B | 0.59692611 |
| 91 | TYRO3 | 0.59337776 |
| 92 | MARK3 | 0.59035558 |
| 93 | JAK2 | 0.57607934 |
| 94 | CSNK1G2 | 0.56150910 |
| 95 | CDK12 | 0.56115160 |
| 96 | SMG1 | 0.55575573 |
| 97 | CSNK1A1L | 0.55439632 |
| 98 | CAMK1D | 0.53924521 |
| 99 | CDK6 | 0.52890491 |
| 100 | PDPK1 | 0.50632104 |
| 101 | MAP2K6 | 0.50226564 |
| 102 | MAP3K1 | 0.49802263 |
| 103 | RPS6KC1 | 0.49363688 |
| 104 | RPS6KL1 | 0.49363688 |
| 105 | ROCK2 | 0.49218143 |
| 106 | PIM1 | 0.48281861 |
| 107 | ALK | 0.48211988 |
| 108 | TESK1 | 0.48071253 |
| 109 | CSNK1G1 | 0.47601085 |
| 110 | DYRK1A | 0.46121045 |
| 111 | MST1R | 0.44534778 |
| 112 | EPHB2 | 0.44331600 |
| 113 | MAPK4 | 0.43865461 |
| 114 | KSR2 | 0.42471587 |
| 115 | BRAF | 0.42358980 |
| 116 | DYRK3 | 0.42288916 |
| 117 | MTOR | 0.42058062 |
| 118 | CDK4 | 0.41634974 |
| 119 | RPS6KA2 | 0.41420880 |
| 120 | SGK3 | 0.40961220 |
| 121 | PRKD1 | 0.39972837 |
| 122 | MKNK1 | 0.38743396 |
| 123 | MAPK11 | 0.38553982 |
| 124 | STK24 | 0.38033723 |
| 125 | PDGFRB | 0.37868566 |
| 126 | PRKCZ | 0.37669882 |
| 127 | TRPM7 | 0.37373707 |
| 128 | LRRK2 | 0.37302309 |
| 129 | CSNK1G3 | 0.37023354 |
| 130 | SYK | 0.36725191 |
| 131 | TEC | 0.35487322 |
| 132 | RPS6KA6 | 0.35300234 |
| 133 | CSK | 0.34809662 |
| 134 | SGK1 | 0.34677413 |
| 135 | LCK | 0.34088912 |
| 136 | MAP3K11 | 0.33754707 |
| 137 | FER | 0.33660378 |
| 138 | TXK | 0.32758485 |
| 139 | UHMK1 | 0.32128120 |
| 140 | PDK3 | 0.31352681 |
| 141 | PDK4 | 0.31352681 |
| 142 | ACVR1B | 0.30945925 |
| 143 | MAPKAPK2 | 0.30425098 |
| 144 | HIPK2 | 0.30413217 |
| 145 | TGFBR1 | 0.30123102 |
| 146 | RPS6KA1 | 0.29271908 |
| 147 | LIMK1 | 0.29186723 |
| 148 | TSSK6 | 0.29129569 |
| 149 | PDK1 | 0.28345376 |
| 150 | BMX | 0.26893770 |
| 151 | SGK2 | 0.26826735 |
| 152 | CSNK1E | 0.26761496 |
| 153 | CDK14 | 0.26304450 |
| 154 | ROCK1 | 0.26023109 |
| 155 | PRKG1 | 0.25815770 |
| 156 | FGFR2 | 0.25771958 |
| 157 | NTRK3 | 0.25410457 |
| 158 | PDGFRA | 0.24871805 |
| 159 | FGFR4 | 0.24589176 |
| 160 | PAK1 | 0.24350594 |
| 161 | BMPR2 | 0.24312888 |
| 162 | PAK2 | 0.24022692 |
| 163 | YES1 | 0.23840623 |
| 164 | ERBB4 | 0.23735512 |
| 165 | ABL1 | 0.23695402 |
| 166 | STK38 | 0.22888202 |
| 167 | GRK6 | 0.22882885 |
| 168 | BRD4 | 0.22874448 |
| 169 | TAOK1 | 0.22732586 |
| 170 | CDK15 | 0.22712752 |
| 171 | TGFBR2 | 0.22516987 |
| 172 | FGFR1 | 0.22132995 |
| 173 | SRC | 0.21818546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.16989807 |
| 2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.15825766 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.12308594 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.92062109 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.89362279 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.69946555 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.59348635 |
| 8 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.54669504 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47909316 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46165619 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.45992762 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44989751 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.39765201 |
| 14 | Malaria_Homo sapiens_hsa05144 | 2.33958451 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 2.33642511 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 2.31691911 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.25200086 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 2.24848960 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 2.23282011 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.21157195 |
| 21 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.15869794 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.14056715 |
| 23 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.11603130 |
| 24 | Protein export_Homo sapiens_hsa03060 | 2.07418949 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.01326671 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.00449233 |
| 27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.95031196 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.93576377 |
| 29 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.92771836 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.89999019 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.89369969 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.89210899 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.87717684 |
| 34 | * Tuberculosis_Homo sapiens_hsa05152 | 1.86304333 |
| 35 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.84795498 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.78428342 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78270568 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.77703032 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.75606196 |
| 40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.74554511 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.73934733 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72044414 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.71551368 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.69546105 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.68246391 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.67627954 |
| 47 | Insulin secretion_Homo sapiens_hsa04911 | 1.62212319 |
| 48 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.60455838 |
| 49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.57525976 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.55524417 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.55452733 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.52997986 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48581470 |
| 54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.48041607 |
| 55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.45758035 |
| 56 | Measles_Homo sapiens_hsa05162 | 1.41167459 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 1.30758671 |
| 58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29277927 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28751554 |
| 60 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28745418 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.28193946 |
| 62 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26615681 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.25559770 |
| 64 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.21638315 |
| 65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.21540448 |
| 66 | Shigellosis_Homo sapiens_hsa05131 | 1.20503643 |
| 67 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19888984 |
| 68 | Hepatitis B_Homo sapiens_hsa05161 | 1.14937513 |
| 69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.13847894 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13301834 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 1.13081548 |
| 72 | Histidine metabolism_Homo sapiens_hsa00340 | 1.12280331 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 1.10061624 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.08326318 |
| 75 | Apoptosis_Homo sapiens_hsa04210 | 1.07779317 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.06590150 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 1.06325852 |
| 78 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03433149 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 1.02205975 |
| 80 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01826000 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01749112 |
| 82 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.01745437 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.98563821 |
| 84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97840263 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.95534551 |
| 86 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.95391314 |
| 87 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91570906 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89741316 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.86731565 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80385362 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.80348858 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79823908 |
| 93 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79675951 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79452621 |
| 95 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78919671 |
| 96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78652784 |
| 97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78581771 |
| 98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76092249 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75112803 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72537251 |
| 101 | Focal adhesion_Homo sapiens_hsa04510 | 0.71870846 |
| 102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71779959 |
| 103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71353223 |
| 104 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.70162546 |
| 105 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.69146862 |
| 106 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68371388 |
| 107 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.68206060 |
| 108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67365175 |
| 109 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65657278 |
| 110 | Peroxisome_Homo sapiens_hsa04146 | 0.64066029 |
| 111 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.63797080 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63136053 |
| 113 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62091569 |
| 114 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61551572 |
| 115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.61128254 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52444063 |
| 117 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52415748 |
| 118 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51539319 |
| 119 | GABAergic synapse_Homo sapiens_hsa04727 | 0.50984393 |
| 120 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.49430281 |
| 121 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.49267960 |
| 122 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48991734 |
| 123 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48652162 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47479604 |
| 125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45333042 |
| 126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44469998 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44417034 |
| 128 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.44030297 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43150948 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.42636645 |
| 131 | Amoebiasis_Homo sapiens_hsa05146 | 0.42515080 |
| 132 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42215003 |
| 133 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41955863 |
| 134 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40925606 |
| 135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40863261 |
| 136 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40424775 |
| 137 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39329091 |
| 138 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39205462 |
| 139 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39100955 |
| 140 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.38955583 |
| 141 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38891113 |
| 142 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.38504940 |
| 143 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37886856 |
| 144 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37211526 |
| 145 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37039934 |
| 146 | Bladder cancer_Homo sapiens_hsa05219 | 0.36117314 |
| 147 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35897156 |
| 148 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.35803526 |
| 149 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.34826815 |
| 150 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33779095 |
| 151 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31985251 |
| 152 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31904451 |
| 153 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31656558 |
| 154 | Circadian entrainment_Homo sapiens_hsa04713 | 0.31369525 |
| 155 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.31365016 |
| 156 | Tight junction_Homo sapiens_hsa04530 | 0.31356861 |
| 157 | Prion diseases_Homo sapiens_hsa05020 | 0.31139938 |
| 158 | * Steroid biosynthesis_Homo sapiens_hsa00100 | 0.30510222 |
| 159 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.30336473 |
| 160 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.30181546 |
| 161 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29462315 |
| 162 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28442189 |
| 163 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.28026138 |
| 164 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.27434184 |
| 165 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.27373295 |
| 166 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.26095548 |
| 167 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25974461 |
| 168 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25518814 |
| 169 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.24213233 |
| 170 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.23014763 |
| 171 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.22992471 |
| 172 | Endocytosis_Homo sapiens_hsa04144 | 0.22466039 |
| 173 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.19570120 |
| 174 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.18853665 |

